Free Account Opening + AMC Free Demat
Loading...

Tatva Chintan Pharma IPO vs Zomato IPO

Comparision between Tatva Chintan Pharma IPO and Zomato IPO.

IPO Details

Tatva Chintan Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Zomato IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Tatva Chintan Pharma IPO is up to ₹500.00 Cr whereas the issue size of the Zomato IPO is up to ₹9,375.00 Cr. The final issue price of Tatva Chintan Pharma IPO is ₹1,083.00 per share and of Zomato IPO is ₹76.00 per share.

  Tatva Chintan Pharma IPO Zomato IPO
Face Value ₹10 per share ₹1 per share
Issue Price (Lower) ₹1,073.00 per share ₹72.00 per share
Issue Price (Upper) ₹1,083.00 per share ₹76.00 per share
Issue Price (Final) ₹1,083.00 per share ₹76.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 13 shares 195 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹225.00 Cr up to ₹9,000.00 Cr
OFS Issue Size
OFS Issue Size (Amount) up to ₹275.00 Cr up to ₹375.00 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹500.00 Cr up to ₹9,375.00 Cr

IPO Timetable

Tatva Chintan Pharma IPO opens on Jul 16, 2021, while Zomato IPO opens on Jul 14, 2021. The closing date of Tatva Chintan Pharma IPO and Zomato IPO is Jul 20, 2021, and Jul 16, 2021, respectively.

  Tatva Chintan Pharma IPO Zomato IPO
Anchor Bid Date
Issue Open Jul 16, 2021 Jul 14, 2021
Issue Close Jul 20, 2021 Jul 16, 2021
Basis Of Allotment (Tentative) Jul 26, 2021 Jul 22, 2021
Initiation of Refunds (Tentative) Jul 27, 2021 Jul 23, 2021
Credit of Share (Tentative) Jul 28, 2021 Jul 23, 2021
Listing date (Tentative) Jul 29, 2021 Jul 23, 2021
Anchor Lockin End date 1 Aug 25, 2021 Aug 21, 2021
Anchor Lockin End date 2 Oct 24, 2021 Oct 20, 2021

Financials

Tatva Chintan Pharma IPO P/E ratio is , as compared to Zomato IPO P/E ratio of .

  Tatva Chintan Pharma IPO Zomato IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 3,148.03 2,489.38 1,875.08
Total Revenue 3,062.92 2,646.22 2,068.01
Profit After Tax 522.62 377.89 205.43
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 87,035.43 29,003.82 34,134.05
Total Revenue 21,184.24 27,427.39 13,977.17
Profit After Tax (8,164.28) (23,856.01) (10,105.14)
Promoter Shareholding (Pre-Issue) 100%
Promoter Shareholding (Post-Issue) 79.17%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Tatva Chintan Pharma IPO retail investors (RII) are offered 16,30,941 shares while in Zomato IPO retail investors are offered 16,30,941 shares. Qualified institutional buyers (QIB) are offered 9,31,966 shares in Tatva Chintan Pharma IPO and 38,88,37,690 shares in Zomato IPO.

  Tatva Chintan Pharma IPO Zomato IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 9,31,966 shares 38,88,37,690 shares
NII 6,98,975 shares 19,43,37,499 shares
RII 16,30,941 shares 12,95,58,333 shares
Employee 0 shares 65,00,000 shares
Others
Total 32,61,882 shares 71,92,33,522 shares

Bids Received (Subscription)

Tatva Chintan Pharma IPO subscribed 180.36x in total, whereas Zomato IPO subscribed 38.25x.

  Tatva Chintan Pharma IPO Zomato IPO
QIB (times) 185.23x 51.79x
NII (times) 512.22x 32.96x
Big NII (times)
Small NII (times)
RII (times) 35.35x 7.45x
Employee (times) 0.62x
Other (times)
Total (times) 180.36x 38.25x

Comments

Add a public comment...